Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Researchers have identified 15 key blood proteins that are expressed differently in Kenyan women who have exhibited resistance to HIV infection than they are among women who are susceptible to infection. About half these proteins were more common in the resistant women, while half were less common. Researchers plan to create microbicides that mimic the proteins' functions and concentrations. --------------------- Early studies of the Ardea Biosciences experimental nonnuke RDEA806 indicate the compound has a high genetic barrier to resistance and little cross-resistance with other meds in its class, according to researchers reporting at the 48th International Conference on Antimicrobial Agents and Chemotherapy. --------------------- Norvir, when used with interferon-based hepatitis C treatment, can hamper the effectiveness of hepatitis therapy, researchers reported at ICAAC. Ziagen was shown to have no adverse effect. A second study presented at the Ninth International Congress on Drug Therapy in HIV Infection has shown that both Reyataz and Intelence are safe and well tolerated among HIVers coinfected with hepatitis B or C. --------------------- Lexiva is just as effective with a lower 100-milligram booster dose of Norvir as with the currently recommended 200-milligram booster, according to a study presented at ICAAC. --------------------- TAT2, a chemical found in plants that are commonly used in Chinese herbal therapy, can prolong the life of the immune system's killer T cells, allowing them to fight HIV longer, according to a study in the November 15 edition of the Journal of Immunology. Researchers now hope to develop TAT2-based treatments to slow HIV disease progression. --------------------- Investigational HIV maturation inhibitor bevirimat was shown to significantly suppress HIV viral levels in treatment-experienced HIVers with infections resistant to at least one anti-HIV medication, according to results of a Phase II clinical study. --------------------- A comparison of Epzicom and Truvada, taken in combination with Kaletra, indicates that both medications have comparable virologic efficacy and safety among both treatment-experienced and treatment-naive HIVers through 96 weeks of therapy. --------------------- A Phase III study of Isentress has shown that the integrase inhibitor is more effective in boosting CD4-cell levels and has significantly fewer side effects than the nonnucleoside reverse transcriptase inhibitor Sustiva. Isentress's maker, Merck, has filed an application with the Food and Drug Administration for approval of the antiretroviral medication for first-line therapy; it currently is approved only for treatment-experienced HIV-positive individuals. --------------------- GeoVax Labs has announced the launch of a Phase IIa human clinical trial of its experimental 'prime-boost' HIV vaccine, which uses three key HIV proteins to first prime the body's immune system to recognize and attack an invading virus and then boost antiviral activity against it. The trial is under way at 12 sites in North America and South America.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM